Cancer support service firm, Reframe Cancer, conducted research that shows absences due to cancer will cost UK business £1.6 billion in 2024.
The research, that spoke to 500 UK employees with cancer, uncovered that the average employee will be absent from work for 15 weeks. This time off includes: Pre-diagnosis worries and symptoms: 12 days Diagnosis and testing: 16 days Treatment: 24 days Recovery: 23 days The research also showed the point at which employees told their employer, 55% told their employer after their cancer diagnosis was been confirmed; 18% disclose when undergoing tests; and 11% wait until they are undergoing treatment or when treatment has finished. Mark Stephenson, CEO, Reframe Cancer, said: "...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.